ESR1 and neoplasm: Additionally, in a cohort of 2046 patients evaluated by Goorts et al. (2017), of all of the tested variables (Estrogen Receptor (ER) status, Progesterone Receptor (PR) status, HER2 amplification, and tumor grade), the most important predictor of pCR was cT-stage [9].